Before AliveCor’s much-buzzed-about iPhone ECG even received FDA clearance late last year, many in healthcare had already christened it a disruptive innovation. Now that it’s actually on the market, we’re hearing stories that prove their case.
The first involved a patient with a cardiac implant who awoke in the middle of the night with cardiac symptoms. His doctor had prescribed him the AliveCor product, so he used it to take his ECG. He tried to get in touch with his cardiologist to interpret the data and let him know what to do next, but the physician couldn’t be reached. Unsure what to do next, the patient tweeted out his ECG reading. Several cardiologists responded with a diagnosis, including Eric Topol, director of the Scripps Translational Science Institute and chief academic officer for Scripps Health.